STOCK TITAN

Fidus Investment (FDUS) 424B Filings

FDUS NASDAQ

Every 424B that Fidus Investment Corp. (FDUS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow FDUS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FDUS filings page.

Rhea-AI Summary

Fidus Investment Corporation (FDUS) is conducting an exchange offer for $120,000,000 aggregate principal amount of its privately placed 6.625% Notes due 2029, issuing an equal principal amount of SEC-registered notes with substantially identical terms. The offer expires at 5:00 p.m. New York City time on October 16, 2026, and Fidus will receive no cash proceeds; tendered restricted notes will be retired.

The exchange notes are senior unsecured obligations maturing on June 1, 2029, ranking equally with other senior unsecured debt but effectively subordinated to secured borrowings and structurally subordinated to subsidiary liabilities. As of September 8, 2026, Fidus had $700.5 million of debt outstanding, including $80.3 million under a secured SPV credit facility and $289.5 million in SBA debentures. The notes are redeemable at Fidus’s option (with a make-whole before a par call date) and must be offered to be repurchased at 100% of principal plus accrued interest upon a Change of Control Repurchase Event. The notes will not be listed on an exchange, and the indenture provides limited protective covenants, so holders bear credit, subordination and liquidity risk.

Rhea-AI Summary

Fidus Investment Corporation is updating its ongoing at-the-market common stock offering of up to $400,000,000. From November 10, 2022 through June 30, 2026, it sold 13,300,342 shares under the program for gross proceeds of $265.2 million and net proceeds of $261.8 million. As of August 4, 2026, $134.8 million of common stock capacity remains available for sale.

The filing details investor cost estimates: a 1.50% sales load, offering expenses of 0.32%, and total stockholder transaction expenses of 1.82% of the offering price. Ongoing annual expenses equal 13.32% of net assets after a small base management fee waiver, or 6.77% when measured against average consolidated total assets, reflecting the use of leverage. As of June 30, 2026, Fidus had $296.0 million in SBA debentures, $320.0 million of unsecured notes, and borrowings under a $225.0 million SPV credit facility.

Illustrative examples show that a $1,000 investment could incur cumulative expenses of $146 over one year and $909 over ten years at a 5.0% annual return. The filing also lists recent trading ranges versus net asset value; on August 4, 2026, the last reported share price was $20.47.

Rhea-AI Summary

Fidus Investment Corporation filed a prospectus supplement registering an at-the-market equity program to offer up to $400,000,000 of common stock under an Equity Distribution Agreement. Through December 31, 2025, the company sold 13,300,342 shares for gross proceeds of $265.2 million, leaving approximately $134.8 million available under the ATM Program.

The supplement states the company will not issue shares below then-current net asset value in connection with this offering; the NAV per share was $19.55 as of December 31, 2025 and the market close price was $18.40 on February 26, 2026. Sales agents may receive commissions up to 1.50% of gross proceeds, and the Adviser may elect to pay some or all commissions. Expected net proceeds if the remaining $134.8 million is sold are approximately $132.3 million, to be used for debt repayment, new investments and working capital.

Rhea-AI Summary

Fidus Investment Corporation filed Supplement No. 5 to its prospectus for an at-the-market program to sell up to $300,000,000 of common stock.

From November 10, 2022 through September 30, 2025, the company sold 11,693,846 shares for $233.5 million in gross proceeds and $230.3 million net after commissions and expenses. As of November 4, 2025, approximately $64.9 million of capacity remains under the ATM program. Sales agent commissions are up to 1.50% of the offering price, and offering expenses are estimated at $1.0 million ($0.8 million incurred as of November 4, 2025). The filing also updates illustrative expense ratios for investors and presents recent trading ranges; the last reported sale price on November 4, 2025 was $20.61 per share.